Home
Pre-Filled Syringes 2020

SAE Media Group is proud to present the 12th Annual Pre-Filled Syringes and Injectable Drug Devices Conference in London on 15th and 16th January 2020.

As Europe’s leading PFS conference and given the key factors driving the market, we will assess advancements in design controls and applications for injectable products, enhancement of  the user interface and human factors, and optimisation of formulation and containment interaction considerations.

The rapid expansion of the PFS market and the regulatory environment are more important than ever, this year’s programme will also take a look at the EU MDR, Article 117, ISO change management standard as well as insights into the MDR post-market safety report, providing a holistic review of the Pre-Filled Syringes industry.

This two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more.

We look forward to welcoming you to the conference in January.

This is our most sought-after event and will be sold out soon.
Early registration is strongly advised to avoid disappointment.

 

FEATURED SPEAKERS

Abha Raveau-Violette

Abha Raveau-Violette

Device Manager, AstraZeneca
Alison Bascou

Alison Bascou

Senior Manager Regulatory Affairs, Beckton Dickinson (BD)
Amanda Matthews

Amanda Matthews

Senior Director, Pfizer UK Limited
Anil-Kumar Busimi

Anil-Kumar Busimi

Strategy and Innovation, Senior Global Product Manager, iQ Platform, SCHOTT Pharmaceutical Systems
Benjamin Werner

Benjamin Werner

Scientist, Boehringer Ingelheim Pharma GmbH & Co. KG
Cedric Gysel

Cedric Gysel

Healthcare Solutions Manager, Johnson & Johnson
Christa Jansen-Otten

Christa Jansen-Otten

Director Global Product Management, Prefilled Systems & Delivery, West Pharmaceutical Services
Christian Helbig

Christian Helbig

VP Glass Syringe Business , SCHOTT Pharmaceutical Systems
Clemens Guenther

Clemens Guenther

Director Nonclinical Safety Consumer Care, Bayer
Colin Roscoe

Colin Roscoe

Principal Human Factors Scientist, Teva Pharmaceuticals
Hiroki  Hasegawa

Hiroki Hasegawa

Researcher, Mitsubishi Gas Chemical Company, Inc
James Mellman

James Mellman

Device Manager, Novartis A G
Jochen Heinz

Jochen Heinz

Director New Products and Technology, Transcoject GmbH
Kewei Yang

Kewei Yang

Pharmaceutical Scientist, Roche
Marion Westwood

Marion Westwood

Pharmaceutical Assesor, Medicines & Healthcare products Regulatory Agency (MHRA)
Matthew Nicolas

Matthew Nicolas

Investigator, GlaxoSmithKline
Nicolas Brandes

Nicolas Brandes

Director Global Product Management Polymer Prefilled Systems and Vial Containment, West Pharmaceutical Services
Olaf Lebau

Olaf Lebau

Design Engineer for Medical Devices and Combination Products, Boehringer Ingelheim GmbH
Orfeo Niedermann

Orfeo Niedermann

Business Development Director, Ypsomed
Reinhard Scheller

Reinhard Scheller

Commercial Manager COP Europe, Zeon Europe GmbH
Remy Vomscheid

Remy Vomscheid

Director, Devices Development & Technologies, IPSEN Pharmsciences
Torsten Kneuss

Torsten Kneuss

Quality Assurance Manager Combination Products, Bayer Pharma

Abha Raveau-Violette

Device Manager, AstraZeneca
Abha Raveau-Violette

Abha Raveau-Violette has a Masters in Mechanical Engineering from the State University of New York with over 11 years of experience in design, development, and manufacturing of Combination Products and Medical Devices in Europe and the US.

She has developed complex endovascular devices, combination products and managed high impact legacy products with a wide range of application from endovascular devices to injectables. These include pre filled syringes, autoinjectors, stents and stent delivery systems.

Her personal motto is the quote from Maya Angelou, ‘People will forget what you said, people will forget what you did but people will never forget how you made them feel’ and she brings this to life by helping improve patients’ lives by solving complex device problems.
 

Alison Bascou

Senior Manager Regulatory Affairs, Beckton Dickinson (BD)
Alison Bascou

Alison Bascou is currently Senior Regulatory Affairs Manager for Regional Customers in US, Europe, Latin America & Greater Asia at BD Medical-Pharmaceutical Systems located in France. In her current role, she leads a team dedicated to supporting customers in their WW registrations of drug-device combination products and medical devices.
Prior to this role, she held positions of increasing responsibility in customer facing teams and innovation product projects. Prior to joining BD in 2012, she worked in generic pharmaceutical companies in France and Germany.
Alison Bascou holds a PhD in Chemistry from the RWTH University of Aachen (Germany), a Chemical Engineering degree from the Ecole Centrale in Marseille (France) as well as a Master in Health Law from the Universities of Sceaux & Châtenay-Malabry (France).

 

Amanda Matthews

Senior Director, Pfizer UK Limited
Amanda Matthews

Amanda has 20 years industry experience working at Pfizer, UK. Her career started as an Analytical Chemist before moving into the Regulatory field. For the past 15 years Amanda’s focus has been providing strategic support to global development programs and lifecycle management for a range of medical device and combination products. Amanda is an active participant in industry associations, namely CPC and EFPIA/EBE working groups focusing on drug-device combinations. Amanda is a contributor to ISO/TC84 and worked on the pending ISO 20069 standard for assessment of changes to drug delivery systems as well as contributing to ISO 11608 revisions.

Anil-Kumar Busimi

Strategy and Innovation, Senior Global Product Manager, iQ Platform, SCHOTT Pharmaceutical Systems
Anil-Kumar Busimi

Anil Busimi started his professional career in 2003 at SCHOTT AG in Germany. He worked in different roles including business development, project manager, and consultant in corporate strategy. In 2005, he moved to SCHOTT Pharmaceutical Packaging business and played a key role in building long-term business strategy with sound understanding of market trends, customer needs and competitive landscape. He has more than 10 years experience in product management and innovation. From August 2009 until June 2016, he held various positions in global product management for pre-fillable syringe business including glass and polymer PFS solutions. Currently, he is in the strategy & innovation team as senior global product manager for Cartridges and led the iQ™ Platform market launch. He is a professional speaker at many conferences and seminars on topics related to parenteral primary packaging and drug delivery devices.
He holds M.Sc. degree in Agriculture and Genetics and a MBA.
 

Benjamin Werner

Scientist, Boehringer Ingelheim Pharma GmbH & Co. KG
Benjamin Werner

Benjamin Werner obtained his Master degree in Pharmacy from the University of Munich. After his education Mr. Werner joined the group of Prof. Dr. Gerhard Winter at the Chair of Pharmaceutical Technology and Biotechnology at the University of Munich for his PhD and visited the University of Kansas for a research stay. During his studies he took part in collaborations with the industry and gained experience in the area of protein formulation, stabilization and analysis. In the last years he focused on novel primary packaging materials and other strategies to diminish protein particles in solutions which may cause immunogenicity after administration. Mr. Werner joined Boehringer Ingelheim last year as a Scientist. He is responsible for the primary packaging and process development of parenteral drugs.

Carsten Worsoe

Principal Scientist, Novo Nordisk
Carsten Worsoe

Cedric Gysel

Healthcare Solutions Manager, Johnson & Johnson
Cedric Gysel

Cedric is a Healthcare Solutions Manager at Johnson&Johnson Design where he is responsible for Patient Centered Design initiatives supporting Janssens (Pharmaceutical Companies of J&J) R&D and Supply Chain portfolio driving better outcomes and user experience using a care centered approach. He holds a Master in Medical Device Technology from the University of Applied Science at Bern, Switzerland and has more than 10 years of experience in device development and lifecycle management.

Christa Jansen-Otten

Director Global Product Management, Prefilled Systems & Delivery, West Pharmaceutical Services
Christa Jansen-Otten

Since joining West in 2005 Christa has become an expert in Prefillable Systems and Delivery Technology in the Technical Customer Service and Marketing Departments. She has 20 years’ experience within the pharmaceutical industry, working in Quality in sterile filling, packaging and syringe manufacturing. She has been in her current position in West since 2016.

Christa holds a Diploma in Biomedical Engineering from the University of Aachen, Germany.
 

Christian Helbig

VP Glass Syringe Business , SCHOTT Pharmaceutical Systems
Christian Helbig

Christian Helbig is the business leader of the Strategic Business Field Glass Syringes at SCHOTT, based in Switzerland.

Mr. Helbig has more than 10 years of experience in pharmaceutical packaging sector, developing advanced pharmaceutical packaging i.e. surface modifications and coatings on glass and polymer, understanding of drug-container interaction investigations. Further, he has been working on development and commercialization of prefilled glass syringes (syriQ®) and and polymer syringes (TopPac®) including closure systems and compatibility with injection devices for various applications in various markets.
He is a biotechnology engineering degree with emphasis in process engineering from University of Applied Sciences Emden/ Leer.
 

Clemens Guenther

Director Nonclinical Safety Consumer Care, Bayer
Clemens Guenther

Dr. Clemens Günther received his diploma in biology and doctorate for natural sciences from the Free University, Berlin-Germany.
He started his professional career in 1990 at Schering AG, Berlin-Germany.
From 2007 to 2013, Dr. Clemens Günther was Director and Head of Global Preclinical Development at Intendis GmbH, branded later-on as Bayer Dermatology. In this position, he was responsible for Nonclinical Safety for the marketed product portfolio of Bayer Dermatology as well as the global preclinical development strategy including human DMPK for development and life cycle management projects.
After integration of Intendis into Bayer in 2013, he became Director Nonclinical Safety Consumer Care within the Division of Bayer Pharmaceuticals.
Meanwhile Dr. Clemens Günther has gained about 30 years experience in drug development. He has been involved in nonclinical development and regulatory toxicology of small molecules, biologics, medical devices and drug device combination products.
 

Colin Roscoe

Principal Human Factors Scientist, Teva Pharmaceuticals
Colin Roscoe

BSc (Hons), Diploma of Professional Studies
2 years at Teva including experience on Specialty, Generic and Biosimilar projects. These projects include Prefilled syringe, Autoinjector, Reconstitution Kits and Container Closures and device peripherals at various stages of devolvement from pre-submission to remediation. Intended applications have included Osteoporosis, Antipsychotics, Migraine, Oncology and Eyedroppers
6 years professional experience as a Human Factors Scientist / Ergonomist working at both Ford and Bombardier. Experience with Motion Capture, Investigative and Applied Ergonomics, Vison Ergonomics Research, Production Line Design, HF Design Assurance, User trials of prototype technologies
 

Enitan Taiwo

Senior Medical Device Specialist, MHRA
Enitan Taiwo

Hiroki Hasegawa

Researcher, Mitsubishi Gas Chemical Company, Inc
Hiroki  Hasegawa

Mr. Hiroki Hasegawa is a researcher of Advanced Business Development Division.
He gained a Diploma in Science in 2013 and a Master Degree of Science in 2015 from Osaka University.
Since April 2015 he has been working for Mitsubishi Gas Chemical Company, Inc. and in charge of macromolecular science, especially in composition development of thermosetting resin.
Since 2018 he has joined a development team of multilayer plastic vial & syringe for biologics.
 

Horst Koller

CEO, HK Packaging Consulting GmbH
Horst Koller

Prior to becoming a consultant, Horst worked for Abbott Diagnostic and SCHOTT Pharmaceutical Packaging with a total of more than 20 years industry experience. His consulting company is focusing on Technical,
Regulatory and QM-Support around Primary and Secondary Packaging Systems including Medical Devices. He is an active member within the technical ISO Committees TC76 and TC84 as well as an active speaker on international conferences. He holds an Engineering degree in Biotechnology from the University of Applied Sciences in Mannheim / Germany.
 

James Mellman

Device Manager, Novartis A G
James Mellman

James is a device manager for Novartis in Basel, Switzerland. His main responsibilities include developing primary packaging systems for combination products and supporting new technologies. He has worked on a multitude of injection device platforms including pre-filled syringes, needle safety devices, auto injectors, and patch injectors. He has also helped to build and implement a renovated CCIT strategy for the Novartis Group. Before Novartis, James worked at Pfizer in their Devices Center of Excellence in Cambridge, UK (2008-2011) and Nutricia in their Advanced Medical Nutrition Division HQ in Amsterdam, NL (2011-2014). He received his PhD from the University of Florida in Materials Science & Engineering in 2007 specializing in biomaterials.

Jochen Heinz

Director New Products and Technology, Transcoject GmbH
Jochen Heinz

o Master of Engineering for Material-science and -Technology
o Dissertation in cooperation with Schott Glas about optical glasses
o Since 1991 at Schott Glas / Central Research concerned with different topics
o Since 1995 at Schott Glas / Pharmaceutical Packaging development of prefillable plastic containers, since 1999 Head of New-Product Development
o Since 2001 at Transcoject in different position.
 

Kewei Yang

Pharmaceutical Scientist, Roche
Kewei Yang

Dr. Kewei Yang is a pharmaceutical scientist and project leader in F. Hoffmann-La Roche Ltd. (Switzerland), Department of Pharmaceutical Development & Supplies, specializing in development of parenteral drug products for both small and large molecules, device combination products, manufacturing process, evaluation of novel advanced drug delivery systems.
Before joining Roche he has worked on the development of nano-medicine for parenteral application in Novartis in Switzerland. Dr. Yang studied pharmaceutical science in Peking University in China and obtained his PhD degree of pharmaceutical technology in Friedlich-Schiller University of Jena in Germany. He has published dozens of papers and a few patents.
 

Lara Chapman

Business Development Manager, BSI Group
Lara Chapman

Lise Vanderkelen

Department Head, Nelson Labs NV
Lise Vanderkelen

Lise Vanderkelen received her Ph.D. from the Faculty of Bioscience Engineering at the University of Leuven (Belgium) in 2012. She started at Nelson Labs Europe (formerly Toxikon Europe) in 2013 as study director at the Extractables & Leachables Department, focusing on Injectables and Parenterals and in 2014 she became responsible for the chemical characterization testing for the medical device industry. In 2016, she became Department Head Pharma Services at Nelson Labs Europe. The main focus of this department is identifying organic impurities in drug products as well as in use stability of drug-device combination. In 2017, the scope expanded and includes now also all microbiological testing offered at Nelson Labs Europe.

Marion Westwood

Pharmaceutical Assesor, Medicines & Healthcare products Regulatory Agency (MHRA)
Marion Westwood

Dr Marion Westwood, is a senior pharmaceutical assessor from the Medicines and Healthcare products Regulatory Agency (MHRA) licensing division. She is an assessor in the team responsible for oncology and rheumatology products.

Marion completed her PhD in drug delivery from biomaterials at Queens University, Belfast.
She has worked at the MHRA for more than 9 years and has a wide range of experience in regulatory processes for almost all types of submissions, including generic applications and new active substances.
Marion has a particular interest in drug device combination products and is a member of the internal drug-device combination working group at the MHRA. She is also involved in the assessment of Notified Body consultations for ancillary medicinal substances in devices.
 

Matthew Nicolas

Investigator, GlaxoSmithKline
Matthew Nicolas

Nicolas Brandes

Director Global Product Management Polymer Prefilled Systems and Vial Containment, West Pharmaceutical Services
Nicolas Brandes

Nicolas Brandes has worked within the pharmaceutical packaging industry for ten years in areas of business development, research & development, technical services and marketing.
Currently in his role as Director Global Product Management, Nicolas is responsible for defining new market requirements, launching new products, supporting business development plans, and overall execution of global marketing strategies, all related to West’s portfolio of polymer container solutions.
Dr. Brandes received his Ph.D. in Biology from the University of Wurzburg, Germany, after performing his research studies at the University of Michigan, USA.
 

Olaf Lebau

Design Engineer for Medical Devices and Combination Products, Boehringer Ingelheim GmbH
Olaf Lebau

Design Engineer for Medical Device and Combination Products, Boehringer Ingelheim

Olaf is an applied physicist by training with a broad knowledge in interdisciplinary fields like nanotechnology and biomimetics.
Over the years, he has worked on extracorporeal circuits, in vitro diagnostic, predictive algorithms and complex drug delivery systems.

After joining Boehringer Ingelheim, he is currently working on combination products for new pharmaceuticals as well as innovation projects for smart and connected drug delivery devices.
 

Orfeo Niedermann

Business Development Director, Ypsomed
Orfeo Niedermann

Orfeo Niedermann has been with Ypsomed since 2005 working with pharma and biotech partners to develop and bring to market innovative self-injection systems. He studied mechanical engineering at the ETH Zurich (MSc ETH) and management in Berne (MBA BFH) and has worked in various positions in engineering, project management, sales and management of technical products, and for more than 10 years in the field of medical devices.

Reinhard Scheller

Commercial Manager COP Europe, Zeon Europe GmbH
Reinhard Scheller

Professional Experience
2003 – present Commercial Manager Cyclo Olefin Polymers (COP) for Europe at Zeon Europe GmbH , Düsseldorf / Germany
• Responsible for the business development of Zeon’s Cyclo Olefin Polymers (COP) in Europe
• Focus on medical/pharmaceutical , analytical/diagnostical and optical COP applications

1996 – 2003 Sales Manager for Germany at Zeon Deutschland GmbH , Düsseldorf / Germany
1991 – 1996 Sales Representative Speciality Rubbers at Zeon Deutschland GmbH , Düsseldorf / Germany
1980 – 1991 Scientific co-worker at the Institut of Polymer Technology Dresden / Germany (today: Leibniz-Institute of Polymer Research Dresden)
Education
1975 – 1980 Studies of Materials Science (specialisation plastics technology and plastics processing) at Technical University Leuna-Merseburg / Germany
 

Remy Vomscheid

Director, Devices Development & Technologies, IPSEN Pharmsciences
Remy Vomscheid

Remy Vomscheid, Ph.D. has been working in the healthcare industry for the last 16 years. He coached biotech start-ups as Business Developer for Genopole, the biggest French Incubator dedicated to Life Sciences. After this, he joined Johnson & Johnson as Business Development Manager, Medical Devices & Diagnostics, EMEA and later moved to a commercial position as Regional Business Manager for LifeScan, the diabetes diagnostics franchise of J&J. Then, he led the technical development of connected & automated medical devices at Eveon, as Director of Development. As Director, Devices Development & Technologies, he currently leads the development of innovative devices at Ipsen.

Severine Duband

Global Category Manager, Nemera
Severine Duband

Severine Duband joined the marketing team at Nemera in 2018, and is in charge of the parenteral franchise. Ms Duband holds a Masters in Science in Business Marketing from EMLYON Business School, (Lyon, France). She has over ten years’ marketing experience with key competencies including strategic planning, NPD launches, project management, and team leadership in an international environment. At Nemera, she particularly focuses on the range of proprietary products, including Safe’n’Sound® add-on passive safety system & Safelia® autoinjector device.

Torsten Kneuss

Quality Assurance Manager Combination Products, Bayer Pharma
Torsten Kneuss

 Torsten Kneuss studied Business Administration and Engineering. Since 1999 he has been working with pharmaceutical packaging materials, medical devices and combination products, including several years within the field of quality control, development, operations, and pharmacovigilance. Since November 2017 he is, as a Quality Manager Combination Products, responsible for devices and combination products within Bayer AG.
 

sponsors

Conference agenda

clock

12:30

Registration & Coffee

clock

12:55

Testing requirements of Pre-Filled Syringes

clock

13:00

Syringe Systems & Materials

  • Glass / Plastic Materials
  • Glass / Plastic Syringe Manufacturing Processes
  • Advantages & Disadvantage of Syringe Materials
     
  • Horst Koller

    Horst Koller, CEO, HK Packaging Consulting GmbH

    clock

    13:35

    Luer Compliance Requirements

  • ISO 80369-7 Dimensional Requirements
  • ISO 803697 - 20 Testing Requirements
  • Relation to ISO I 1040-4 /-6 (Glass / Plastic Syringes)
  • Horst Koller

    Horst Koller, CEO, HK Packaging Consulting GmbH

    clock

    14:10

    Empty preassembled PFS

  • ISO I1040-4 / -6 Testing Requirements
  • Test Method Descriptions / Explanations
     
  • Horst Koller

    Horst Koller, CEO, HK Packaging Consulting GmbH

    clock

    14:45

    Final filled PFS

  • ISO 11040-8 Testing Requirements
  • Device implementation
     
  • Horst Koller

    Horst Koller, CEO, HK Packaging Consulting GmbH

    clock

    15:20

    Session Recap

    Horst Koller

    Horst Koller, CEO, HK Packaging Consulting GmbH

    clock

    15:30

    Afternoon Tea

    clock

    15:55

    Extractables and Leachables: Considerations for PFS Platforms

    clock

    16:00

    Key considerations for material selection and overview of current testing practices

  • Choice of critical components for drug compatibility in PFS
  • Predictive tools for interactions in PFS
  • Relationship between extractables, simulated leachables and leachables in PFS
  • Study designs for E&L documentation in PFS
     
  • Carsten Worsoe

    Carsten Worsoe, Principal Scientist, Novo Nordisk

    Anders Burild

    Anders Burild, Senior Scientist, Novo Nordisk A/S

    clock

    17:10

    An interactive look at a PFS case study

  • Case studies on extractables and leachables studies in PFS
  • Documentation level for leachables within registration applications containing combination of PFS and drug product
  • Carsten Worsoe

    Carsten Worsoe, Principal Scientist, Novo Nordisk

    Anders Burild

    Anders Burild, Senior Scientist, Novo Nordisk A/S

    clock

    17:45

    How can we improve current processes to prevent unwanted container interactions

  • Safety risk assessments of extractables and leachables in PFS
  • The relationship between ICH Guidelines for impurities (Q3 & M7) and extractable & leachable thresholds
  • Carsten Worsoe

    Carsten Worsoe, Principal Scientist, Novo Nordisk

    Anders Burild

    Anders Burild, Senior Scientist, Novo Nordisk A/S

    clock

    18:20

    Closing Remarks

    Carsten Worsoe

    Carsten Worsoe, Principal Scientist, Novo Nordisk

    Anders Burild

    Anders Burild, Senior Scientist, Novo Nordisk A/S

    clock

    8:00

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    James Mellman, Device Manager, Novartis A G

    Anil-Kumar Busimi, Strategy and Innovation, Senior Global Product Manager, iQ Platform, SCHOTT Pharmaceutical Systems

    clock

    9:10

    Reviewing the current environment in injectable drug delivery

    James Mellman, Device Manager, Novartis A G

  • An industry outlook into recent developments drug delivery platforms
  • How has developments in regulatory guidance effected the current drug delivery environment
  • New opportunities in drug products and what can we learn from the past year
     
  • clock

    9:40

    Design Controls for Combination Products

    Torsten Kneuss, Quality Assurance Manager Combination Products, Bayer Pharma

  • Application of Design Controls to Combination Products – A global perspective
  • Introduction to Design Controls for Combination Products
  • Challenges with Design Controls for Combination Products
     
  • clock

    10:10

    Pre-Fillable Syringes using ZEONEX® 790R – A Case Study 10 ml / 20 ml

  • Introduction and Objective of the study
  • ZEONEX®/ZEONOR® Cyclo Olefin Polymers (COP) – recommended polymers for high end PFS
  • PFS for universal hand-held and power injector use: Design and Requirements
  • Verification testing of product functions for empty and filled containers after accelerated aging
     
  • Reinhard Scheller, Commercial Manager COP Europe, Zeon Europe GmbH

    Jochen Heinz, Director New Products and Technology, Transcoject GmbH

    clock

    10:50

    Morning Coffee

    clock

    11:20

    A User Centered Portfolio Approach for Pharmaceutical Delivery Systems

    Cedric Gysel, Healthcare Solutions Manager, Johnson & Johnson

  • A Sustainable User Centered Portfolio Approach
  • Driving outcomes and better adherence by focusing on the use experience
  • Case studies
  • clock

    11:50

    Syringe integration for use with an Autoinjector

  • Auto-injectors are increasingly used for self-injection therapies for improving user’s convenience and enhancing patient’s compliance, in particular in use with bio therapeutics.
  • Functional interface of the pre-filled syringe and the application system is essential. The presentation will address specific performance features achieved with a PFS system for application with an auto-injector.
  • The joint presentation provides for information on assessing this pre-filled syringe by the application system provider
  • Orfeo Niedermann, Business Development Director, Ypsomed

    Christian Helbig, VP Glass Syringe Business , SCHOTT Pharmaceutical Systems

    clock

    12:30

    Pre-clinical safety considerations for a drug device combination product for injection

    Clemens Guenther, Director Nonclinical Safety Consumer Care, Bayer

  • Drug related aspects
  • Formulation related aspects
  • Device related aspects: Biocompatibility assessment
  • Other components to be evaluated: Impurities, Extractables & Leachables
     
  • clock

    13:00

    Networking Lunch

    clock

    14:00

    Advantages of proactive design space understanding through in-silico modelling and targeted testing

    Matthew Nicolas

    Matthew Nicolas, Investigator, GlaxoSmithKline

  • Proactive approaches to design space understanding
  • Advantages of a modelling-based approach
  • Practical examples
  • Business advantages
     
  • clock

    14:30

    Pain perception and injection devices: could pain be assessed through non-human person trials in early stage device development?

    Severine Duband, Global Category Manager, Nemera

  • Pain perception during injection: what are the key drivers
  • Could a study on non-human primate evaluate the pain sensitivity associated to an injection?
  • Conclusion
     
  • clock

    15:10

    Human Factors Engineering for Medical Device Development

    Remy Vomscheid, Director, Devices Development & Technologies, IPSEN Pharmsciences

  • Human Factors Engineering: overview & regulatory framework
  • Patient-centricity in Device Design & Development
  • Case study: New Delivery System for Somatuline® Autogel®
     
  • clock

    15:40

    Afternoon Tea

    clock

    16:10

    The route to patient centric drug delivery

    Olaf Lebau, Design Engineer for Medical Devices and Combination Products, Boehringer Ingelheim GmbH

  • Patient considerations and pharmaceutical connectivity limitations
  • Cost vs. Adherence, where do the benefits lie?
  • Connectivity, AR and AI – new approaches to patient – drug interaction
  • Realistic patient experience approach
     
  • clock

    16:40

    Human Factors Validation of Prefilled Syringes: Lessons Learned

    Colin Roscoe, Principal Human Factors Scientist, Teva Pharmaceuticals

  • Ducks in a Row: What you need before Human Factors Validation
  • Where Eagles Dare’: Conducting Human Factors Validation
  • Having Kittens: What to do with use errors?
  • From the Horse’s mouth: HF Summary Report
     
  • clock

    17:10

    Chairs’ Closing Remarks and Close of Day One

    James Mellman, Device Manager, Novartis A G

    Anil-Kumar Busimi, Strategy and Innovation, Senior Global Product Manager, iQ Platform, SCHOTT Pharmaceutical Systems

    clock

    18:00

    End of Day One Networking Dinner - Invitation Only

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    James Mellman, Device Manager, Novartis A G

    Anil-Kumar Busimi, Strategy and Innovation, Senior Global Product Manager, iQ Platform, SCHOTT Pharmaceutical Systems

    clock

    9:10

    The new ISO change management standard

    Amanda Matthews, Senior Director, Pfizer UK Limited

    • What’s new and how what is the impact for industry?
    • The key messages of managing change through the product lifecycle
    • Consideration of the standard to ensure effective change management
     

    clock

    9:40

    Regulatory focus on device-components within the new European framework

    Alison Bascou, Senior Manager Regulatory Affairs, Beckton Dickinson (BD)

  • An industry’s view on EU MDR impact on combination products
  • What’s new in the Global Safety and Performance Requirements
  • New submissions and substantial changes

     

  • clock

    10:20

    A regulatory perspective of Combinations products in the European market

    Marion Westwood, Pharmaceutical Assesor, Medicines & Healthcare products Regulatory Agency (MHRA)

  • An overview of the current requirements effective PFS and combination products
  • Updates in the EU MDR and what will be expected from industry
  • How will this effect products currently on the market?
  • An outlook to the future regulatory environment for pre-filled syringes
     
  • clock

    10:50

    Morning Coffee

    clock

    11:20

    Panel Discussion: The EU MDR and Brexit - How can we prepare for the regulatory impact on devices

  • The current regulatory framework in the EU and UK
  • How can industry prepare for the regulatory environment post-Brexit
  • How software in conjunction with medical devices be affected
     
  • Amanda Matthews, Senior Director, Pfizer UK Limited

    Torsten Kneuss, Quality Assurance Manager Combination Products, Bayer Pharma

    James Mellman, Device Manager, Novartis A G

    Enitan Taiwo

    Enitan Taiwo, Senior Medical Device Specialist, MHRA

    Lara Chapman

    Lara Chapman, Business Development Manager, BSI Group

    clock

    12:00

    How unmet market needs drive new packaging solutions for improved drug delivery

  • What are the market trends and unmet needs in primary packaging?
  • What are the latest developments in primary packaging?
  • How does new packaging can help to improve drug delivery and increase value for pharma and patients?

     

  • Christa Jansen-Otten, Director Global Product Management, Prefilled Systems & Delivery, West Pharmaceutical Services

    Nicolas Brandes, Director Global Product Management Polymer Prefilled Systems and Vial Containment, West Pharmaceutical Services

    clock

    12:40

    Change is the only constant: Managing change through the lifecycle of Combination products

    Abha Raveau-Violette, Device Manager, AstraZeneca

  • Reasons for changes: Why change something that works?
  • Regulatory expectations
  • Managing changes through Design Controls
  • Legacy products and changing regulatory landscape
  • Opportunities and challenges
  • clock

    13:10

    Networking Lunch

    clock

    14:10

    Latest Date of OXYCAPT Multilayer Plastic Vial & Syringe

    Hiroki Hasegawa, Researcher, Mitsubishi Gas Chemical Company, Inc

  • Comparison among OXYCAPT, COP and Glass
  • Excellent Oxygen & Ultraviolet Barrier
  • Oxidation and Aggregation Studies of Antibody
  • Development of Staked Needle Syringe
  • clock

    14:50

    Risk Management for Combination Products

    Torsten Kneuss, Quality Assurance Manager Combination Products, Bayer Pharma

  • Introduction to Risk Management for Combination Products
  • Typical pitfalls in the Risk Management for Combination Products
  • Upcoming changes with ISO 14971:2019
     
  • clock

    15:20

    The journey of revealing unknowns and impurities by material knowledge (The origin of species)

    Lise Vanderkelen, Department Head, Nelson Labs NV

  • Material characterization
  • Controlling the unknowns
  • Identifying impurities
  • Case studies
     
  • clock

    16:00

    Afternoon Tea

    clock

    16:30

    Pre-Filled Syringes: A Case Study

    Benjamin Werner, Scientist, Boehringer Ingelheim Pharma GmbH & Co. KG

  • Container closure systems – challenges and considerations
  • Syringe siliconization
  • Container closure integrity testing
     
  • clock

    17:00

    Clogging in staked-in needle pre-filled syringes

    Kewei Yang, Pharmaceutical Scientist, Roche

  • Clarifying the clogging phenomenon of SIN-PFS
  • Understanding the influence of water vapor transmission through a needle shield
  • A non-invasive investigation by neutron imaging confirming that liquid can migrate into the needle
     
  • clock

    17:30

    Chairs' Closing Remarks and Close of Day Two

    James Mellman, Device Manager, Novartis A G

    Anil-Kumar Busimi, Strategy and Innovation, Senior Global Product Manager, iQ Platform, SCHOTT Pharmaceutical Systems


    Device Manager
    AstraZeneca
    Senior Manager Regulatory Affairs
    Beckton Dickinson (BD)
    Senior Director
    Pfizer UK Limited
    Strategy and Innovation, Senior Global Product Manager, iQ Platform
    SCHOTT Pharmaceutical Systems
    Scientist
    Boehringer Ingelheim Pharma GmbH & Co. KG
    Principal Scientist
    Novo Nordisk
    Healthcare Solutions Manager
    Johnson & Johnson
    Director Global Product Management, Prefilled Systems & Delivery
    West Pharmaceutical Services
    VP Glass Syringe Business
    SCHOTT Pharmaceutical Systems
    Director Nonclinical Safety Consumer Care
    Bayer
    Principal Human Factors Scientist
    Teva Pharmaceuticals
    Senior Medical Device Specialist
    MHRA
    Researcher
    Mitsubishi Gas Chemical Company, Inc
    CEO
    HK Packaging Consulting GmbH
    Device Manager
    Novartis A G
    Director New Products and Technology
    Transcoject GmbH
    Pharmaceutical Scientist
    Roche
    Business Development Manager
    BSI Group
    Department Head
    Nelson Labs NV
    Pharmaceutical Assesor
    Medicines & Healthcare products Regulatory Agency (MHRA)
    Investigator
    GlaxoSmithKline
    Director Global Product Management Polymer Prefilled Systems and Vial Containment
    West Pharmaceutical Services
    Design Engineer for Medical Devices and Combination Products
    Boehringer Ingelheim GmbH
    Business Development Director
    Ypsomed
    Commercial Manager COP Europe
    Zeon Europe GmbH
    Director, Devices Development & Technologies
    IPSEN Pharmsciences
    Global Category Manager
    Nemera
    Quality Assurance Manager Combination Products
    Bayer Pharma

    Sponsors

    Exhibitors

    Official Media Partner

    Key Media Partners

    Supporters

    Workshops

    Preliminary Attendees (9th January 2020)

    Download

    Preliminary Attendees

    Download

    Speaker Interview - Raphael Nudelman

    Download

    Speaker Interview - Horst Keller

    Download

    Speaker Interview with Hiroki Hasegawa

    Download

    Speaker Interview with Abha Raveau Violette

    Download

    Speaker interview with James Mellman

    Download

    Speaker interview with Torsten Kneuss

    Download

    Speaker Interview with Cedric Gysel

    Download

    Chair letter

    Download

    2020 Workshop Programme

    Download

    2020 Speaker Biographies

    Download

    2020 Conference Programme

    Download

    Past Attendees List

    Download

    PFS Infographics

    Download

    Presentation by Shota Arakawa, Mitsubishi Gas Chemical

    Download

    Presentation by Reinhard Scheller, Zeon

    Download

    Presentation by Suraj Ramachandran, Merck

    Download

    Presentation by Michael Becker, Boehringer Ingelheim

    Download

    Presentation by Lise Vanderkelen, Nelson Labs

    Download

    Presentation by Kim Soholm Halskov, Novo Nordisk A/S

    Download

    Presentation by Davide Mercadante, Biogen

    Download

    Presentation by Alexander Zurn, Novartis Device Development

    Download

    Sponsors


    BD Medical

    Sponsors
    http://www.drugdeliverysystems.bd.com

    As a partner of choice for the pharmaceutical and biotech companies across the globe, BD Medical - Pharmaceutical Systems provides a broad range of ready-to-use drug delivery systems including glass and plastic prefillable syringes, safety and shielding systems, self-injection systems and connected solutions that help ensure smooth delivery, regardless of drug complexity, viscosity and dosing volume.

    With an unbending emphasis on innovation and the highest level of technical expertise, BD Medical - Pharmaceutical Systems provides pharmaceutical and biotechnology companies with support and resources to help them achieve their goals. We support their product launch and life cycle management through sophisticated consultative, analytical and clinical services to help ensure drug compatibility and seamless systems integration, while accelerating time-to-market and reducing risk.

    More information available @ drugdeliverysystems.bd.com



    Mitsubishi Gas Chemical

    Sponsors
    https://www.mgc.co.jp/eng/products/abd/oxycapt.html

    Mitsubishi Gas Chemical is a leading company in the field of oxygen barrier and absorbing technologies. Based on these technologies and experiences, we have successfully developed multilayer plastic vial and syringe having excellent oxygen, ultra violet and water vapor barrier. The products make it possible to replace glass with plastic for injectable drugs.


    Nelson Labs Europe

    Sponsors
    http://www.nelsonlabs.be

    Nelson Labs Europe is an independent contract research organization, specializing in and fully dedicated to providing premium Extractables & Leachables services to the pharmaceutical industry. Based in Belgium, Nelson Labs Europe supports pharmaceutical companies – across the globe in developing worldwide compliance testing strategies to qualify Container/Closure Applications and Pharmaceutical Production Equipment from an Extractables & Leachables perspective. Over the last 15 years, Nelson Labs Europe supported over 200 submissions to the FDA and to the EMA.

    From a quality perspective, Nelson Labs Europe is ISO 17025 accredited and GLP-certified. Nelson Labs Europe has received a GMP accreditation from the European Authorities.

    Nelson Labs Europe is FDA registered. In 2017, Nelson Labs Europe was successfully audited by the FDA.

    Nelson Labs Europe is part of Nelson Labs, the leading global micro-biological and analytical lab testing platform.

    Nelson Labs, along with sister companies Sterigenics and Nordion, are part of Sotera Health, the world’s leading, fully-integrated protector of global health.



    Nemera

    Sponsors
    http://www.nemera.net

    As a world-leading drug device combination solutions specialist, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are the utmost holistic partner and help our customers succeed in the sprint to market. From early device strategy to state-of-the-art manufacturing, we’re committed to the highest quality standards. Agile and open-minded, we work with our customers as colleagues. Together, we go the extra mile to fulfill our mission. Nemera leverages decades of experience in the parenteral device segment from full development to pure contract manufacturing, through customized solutions. Nemera developed - Safe’n’Sound®, a fully passive safety device for prefilled syringes to avoid accidental needle-sticks and - Wearables, technological bricks combined together into a smart wearable to improve patients’ life.


    SCHOTT

    Sponsors
    http://www.schott.com/pharma

    SCHOTT is a leading supplier of primary pharma packaging and analytical lab services. We provide quality solutions while meeting the highest demands. Our product portfolio includes ampoules, syringes, cartridges and vials made of glass and COC polymer. Our facilities and products comply with international standards for pharmaceutical needs.


    West Pharmaceutical Services, Inc.

    Sponsors
    http://www.westpharma.com/

    West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2017 net sales of $1.6 billion reflect the daily use of approximately 112 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.


    ZEON Europe GmbH

    Sponsors
    http://www.zeon.eu/cop-copf-zeonex-zeonor-zeonorfilm.html

    Zeon Europe GmbH is the European marketing/sales organisation of Zeon Corporation / Japan. As part of specialty materials operations Zeon produces Cyclo-Olefin Polymers (COP) under the tradenames ZEONEX® and ZEONOR®. The balance of outstanding water barrier properties in combination with high purity, excellent chemical resistance, high transparency and low interaction with drugs, put ZEONEX® and ZEONOR® as a perfect alternative to glass or other plastics solutions for pharmaceutical and biopharmaceutical containers - such as Pre-filled syringes, cartridges and vials.

    Exhibitors


    Früh Verpackungstechnik AG

    Exhibitors
    http://www.fruh.ch/

    Früh Verpackungstechnik AG is located in Switzerland and Europe’s leader for contract packaging of medical devices. We have as well the Swiss Medic approval for secondary packaging of pharmaceuticals. Our expertise is the assembling (in ISO class 7 clean rooms) and packaging of pre-filled syringes for sterile applications with respecting cold chain requirements. Früh offers as well the production of pre-made packaging materials (blisters and pouches) in class 7 clean rooms.


    Harro Höfliger

    Exhibitors
    http://www.hoefliger.com

    Harro Höfliger specializes in the development of customer-oriented process and production solutions for pharmaceutical and medical applications as well as market-oriented consumer products. In addition to innovative machine platforms and packaging machines, customized turnkey system solutions for product assembly, processing of web materials, as well as dosing and inhalation technology are the company’s core expertise.

    The systematically structured portfolio of upscalable test machines and modules, as well as requirement-oriented technology platforms, results from many years of experience and targeted research and development. Thus, Harro Höfliger covers all phases from the laboratory stage to high-performance production.



    IPP

    Exhibitors
    http://ippgroupltd.com/

    Industrial Production Processes (IPP) Ltd is a technical distributor of manufacturing equipment to the medical device and pharmaceutical sectors, specialising in packaging equipment, packaging inspection equipment, pre-filled syringe and tablet inspection equipment, automation equipment and serialisation equipment.

    Visit us at the SMI Pre-Filled Syringe Conference 2020, alongside our Packaging Technologies and Inspection partner, PTI, our Container Closure Integrity Testing (CCIT) specialist, and check out its microcurrent HVLD technology – the optimal solution for all parental and biologic products.

    The E-Scan 655 technology is a MicroCurrent conductivity test method, HVLDmc , that is completely non-destructive to the container and product; exposing the package and product to lower voltage than other conductivity based solutions. The technology uses a non-contact and non-invasive test method that requires no sample preparation. PTI’s E-Scan 655 can be used with a wide range of liquid based products including low conductivity sterile water for injection (WFI) and proteinaceous products with suspensions.

    The E-Scan 655 features a fast test cycle and simple operation. Additional benefits include quick changeover and easy recipe setup to accommodate a wide range of products and applications. The offline E-Scan 655 method can be migrated from laboratory to 100% inline testing applications at high production speeds.

    Visit our booth to learn more.



    Owen Mumford

    Exhibitors
    http://www.ompharmaservices.com

    Owen Mumford Pharmaceutical Services is a specialist in the design, development and manufacture of injectable drug delivery systems for the pharmaceutical, biotech & generics industries. These include single dose and multidose reusable and disposable auto-injectors, pens and syringes for subcutaneous and intramuscular administration. Our innovative products are designed to meet both the need of our pharmaceutical partners and their patients by facilitating ease of use and improving safety and patient compliance. Our devices are also designed with aim of reducing complexity and risk for the pharmaceutical & biotech industry in the development of their combination products.


    PHC Corporation

    Exhibitors
    http://www.phchd.com/global

    In April 2018, Panasonic Healthcare Holdings Co., Ltd. changed its name to PHC Corporation.

    For all the people who wish for better health. Over the approximately 70 years since our establishment, we have delivered groundbreaking products to the world. The newly created “PHC” will take on the challenge of providing ever new innovations, drawing on the spirit of monozukuri (Japanese manufacturing).We will continue to evolve as a provider of devices and services marked by PHC's precision technology in our three core business areas of Medical Devices, Healthcare IT, and Life Sciences.



    ZwickRoell

    Exhibitors
    http://www.zwickroell.com

    ZwickRoell manufactures and supports a wide range of materials testing machines, systems and accessories for use in research, quality control, production environments and academia. Our extensive portfolio of testing machines and accessories cover almost every segment, from medical and pharmaceutical packaging to surgical instruments and orthopaedics and biomaterials.

    Media Partners


    ONdrugDelivery Magazine

    Official Media Partner
    http://ondrugdelivery.com

    ONdrugDelivery provides 30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. Subscribe online today to the print or free digital edition: www.ondrugdelivery.com/subscribe.

    Media Partners


    International Pharmaceutical Industry (IPI)

    Key Media Partners
    http://ipimediaworld.com/

    IPI – International Pharmaceutical Industry IPI – was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally. Edited by our carefully selected editorial advisory panel, and extensive research network, IPI provides a proven supportive means of communication to the pharmaceutical, bio pharmaceutical, nutraceutical and medical devices industry the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies which will enable them to be more efficient, bring products to market faster, reduce cost and make healthcare accessible to all.


    pharmanews hq

    Key Media Partners
    http://http://pharmanewshq.com

    MedChemNet provides a unique and unparalleled platform for the medicinal chemistry community to share insights, discuss the latest research, and help move the field forward. MedChemNet covers all aspects of the drug discovery pipeline, from target identification and validation, through computer aided drug design (CADD), synthesis, screening and other biophysical techniques, to development of novel lead compounds and pre-clinical in vivo proof of concept. We also cover the design of synthetic drug delivery carriers and ADME/toxicology studies, as well as intellectual property and economic related issues. Website: Welcome to Pharma News HQ, the journal dedicated to the pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry. Pharmanewshq.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production.


    Pharmaceutical Technology

    Key Media Partners
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    World Pharma News

    Key Media Partners
    http://www.worldpharmanews.com/



    Pharma Journalist

    Key Media Partners
    http://www.pharmajournalist.com

    Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


    pharmaphorum

    Key Media Partners
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com

    Media Partners


    SciDoc Publishers

    Supporters
    http://www.scidoc.org

    SciDoc Publishers is a major source provider of e-journals in the field of Science, Technology and Medicine (STM). The nature of journals - Open Access and Peer-reviewed. We are aimed with a sole motive in making a mark in the field of Open Access, by propagating the knowledge to the scientific community. Our prime concern involves, the knowledge to reach millions of readers and give them access to scientific publications - online.


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Drug Development & Delivery

    Supporters
    http://www.drug-dev.com

    Drug Development & Delivery is a print/online content provider that presents the latest scientific methods in drug development for professionals.


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.


    Select Science

    Supporters
    http://www.selectscience.net/

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.


    Farmavita

    Supporters
    https://farmavitar.com

    FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!


    PharmaVOICE

    Supporters
    http://www.pharmavoice.com

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


    Bio Pharma Trend

    Supporters
    https://www.biopharmatrend.com/

    BiopharmaTrend is a market and business intelligence platform for drug discovery and biotech industry, focusing on emerging areas: artificial intelligence in pharmaceutical R&D, "digitalization" of the pharma industry, and technology/business trends in pre-clinical and clinical drug development. We also publish articles, commentaries and opinions contributed by top industry professionals.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.